Joe Rogan Praises Trump’s Executive Order on Psychedelic Research
Psychedelic research funding is crucial for advancing clinical trials and expanding therapeutic options. Trump's executive order aims to accelerate this funding to improve treatment access. This policy shift could significantly impact clinical research…
Medical Cannabis for Orthopaedic Pain: Promising Signal, Weak Evidence Base
Medical cannabis orthopedic pain is a growing area of patient interest despite limited high-quality evidence. This review highlights promising signals for musculoskeletal conditions but notes weak study designs. Clinicians should consider cannabis as…
Cannabinoid Clinical Trials: Teen Cannabis Intervention Study
Adolescent cannabis use disorder intervention is critical due to neurodevelopmental risks during brain maturation. Clinical trials provide essential data on effective teen cannabis use disorder treatments. Evidence-based interventions remain limited but…
Trump Plans Psychedelic Executive Order (Newsletter: April 17, 2026)
The 2026 psychedelic drug policy developments could reshape access to psilocybin and MDMA treatments currently in FDA trials. These changes matter clinically for patients with PTSD and depression. Clinicians should monitor these developments closely for…
Cannabinoid Clinical Trials: EEG Sleep Insomnia RCT
This pilot trial studied the acute effects oral cannabinoids sleep insomnia in 20 patients. The combination of THC and CBD reduced total sleep time and altered EEG sleep patterns. These findings highlight the complexity of cannabinoid effects on sleep in…
IGC Pharma Nears Completion of Phase 2 CALMA Trial Enrollment
The phase 2 CALMA trial enrollment by IGC Pharma has reached 80%, marking significant progress in cannabis-derived therapeutic research. This trial aims to establish safety and efficacy data for a novel cannabis pharmaceutical candidate. Clinicians…
An Investigation of Cannabis and Mood Study for Class Project ($25 RAFFLE FOR …)
Student-led cannabis research projects often lack proper clinical research standards, impacting data validity. This mood study highlights challenges in informal cannabis research. Clinicians should be aware of these issues when discussing cannabis…
Medical Cannabis Market Growth and Clinical Research Outlook 2026-2033
The medical cannabis market growth 2026 is driven by intensified clinical research and development of pharmaceutical-grade products. Clinicians must stay informed about emerging evidence to guide patient care. This evolving landscape promises more…
Proposed Rule Would Allow Expansion of Cannabis Research in Missouri
Missouri cannabis research expansion is proposed to enable new research facilities focused on cannabis clinical studies. This rule aims to remove restrictions limiting research infrastructure and accelerate evidence development. Clinicians could benefit…
France Extends Experimental Medical Cannabis Access Until 2027
France medical cannabis access extension has been announced, allowing experimental use until 2027. This development is important for cannabis medicine and clinical practice. Clinicians should monitor emerging evidence related to this extension.